search
Back to results

COMORAL® the Oral Irrigation Unit Clinical Trial (COMORAL)

Primary Purpose

Gingivitis, Plaque

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
applying COMORAL®
Sponsored by
University of California, Los Angeles
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Gingivitis focused on measuring COMORAL, the oral irrigation unit

Eligibility Criteria

18 Years - 25 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Healthy adult patients (ASA 1-2) aged 18 to 25 with a probing depth of 3mm or less
  • Those with 3 or more natural teeth in each quartile
  • Those who can voluntarily sign the consent form

Exclusion Criteria:

  • Existing dental caries
  • Existing periodontitis
  • Other oral diseases

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    No Intervention

    Experimental

    Arm Label

    Control group

    Experimental group

    Arm Description

    The individuals in the control group will be asked to brush their teeth (2x per day) at home throughout the 4 weeks of study period. They will be asked not to use the supplementary oral hygiene products including mouth rinse, dental floss and chewing gum.

    The individuals in this group will be asked to brush their teeth (2x per day) at home throughout the 4 weeks of study period. They will be asked not to use the supplementary oral hygiene products including mouth rinse, dental floss and chewing gum. Instead, they will be asked to come to the clinic to use COMORAL® three times a day, every day except Saturday and Sunday.

    Outcomes

    Primary Outcome Measures

    gingival index (GI)
    the scoring system for mild inflammation(modified gingival index)
    plaque index (PI)
    the amount of dental plaque visible on the vestibular and lingual surfaces
    bleeding on probing (BOP)
    the scoring system recorded 20 seconds after probing the depth of the pocket
    pocket depth (PD)
    the distance from the gingival margin to pocket base
    gingival recession (GR)
    the distance of the displacement of marginal gingiva apical to the cemento-enamel junction
    clinical attachment loss (CAL)
    the distance between the cementoenamel junction and the base of the probeable pocket

    Secondary Outcome Measures

    Periopathogens (PP)
    the amounts of s. mutans, p. gingivalis, and f. nucleatum.

    Full Information

    First Posted
    July 20, 2021
    Last Updated
    August 26, 2021
    Sponsor
    University of California, Los Angeles
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05031260
    Brief Title
    COMORAL® the Oral Irrigation Unit Clinical Trial
    Acronym
    COMORAL
    Official Title
    Effect of COMORAL® the Oral Irrigation Unit in Preventing Gingivitis and Plaque Formation
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    August 2021
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    October 1, 2021 (Anticipated)
    Primary Completion Date
    November 30, 2021 (Anticipated)
    Study Completion Date
    June 30, 2022 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    University of California, Los Angeles

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Product Manufactured in and Exported from the U.S.
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    This is a clinical study to evaluate the safety and effectiveness of COMORAL®, the intraoral water-spraying cleaning device that is developed to remove plaque around teeth in the oral cavity. To do so, 42 healthy subjects, 21 control and 21 experimental, will be recruited. To establish the baseline, all subjects will receive dental hygiene service. After 2 weeks, patients will be randomly assigned to either control or intervention group (21 individuals each). Both groups will be asked to brush their teeth once a day but without dental floss, mouth rinse, and gum chewing, throughout the 4 weeks of study period. During the study period, the experimental group will receive COMORAL® treatment three times a day every day for 4 weeks except Saturday and Sunday. Subjects will get evaluated for the oral status(PI, BOP, GI, PD, GR, CAL) and the status of periopathogens on visit 1, visit 2 and visit 3.
    Detailed Description
    This is a randomized, open-labeled, single-centered clinical study to evaluate COMORAL® the intraoral water-spraying cleaning device that is developed to remove plaque around teeth in the oral cavity. The purpose of this clinical study is to evaluate the safety and effectiveness of COMORAL® the oral irrigation unit in preventing gingivitis and plaque formation in adult patients. 42 patients between 18 to 25 years old who have a periodontal probing depth of 3 mm or less will be recruited. To establish the baseline, all the patients will receive dental hygiene service. After 2 weeks (Visit 1), patients will be randomly assigned to either control or intervention group (21 individuals each). They will be asked to do the following instruction; Control group (21 total) - The individuals in the control group will be asked to brush their teeth once a day at home throughout the 4 weeks of study period. They will be asked not to use the supplementary oral hygiene products including mouth rinse, dental floss and chewing gum. Experimental/Intervention group (21 total) - The individuals in this group will be asked to brush their teeth once a day at home throughout the 4 weeks of study period. They will be asked not to use the supplementary oral hygiene products including mouth rinse, dental floss and chewing gum. Instead, they will be asked to come to the clinic to use COMORAL® three times a day, every day except Saturday and Sunday. Subjects in both groups will be evaluated for clinical indices (PI, BOP, GI, PD, GR, CAL) and the status of periopathogens on visit 1(baseline, visit 2(after 2 weeks), and visit 3(after 4 weeks). To measure the status of periopathogens, 3ml of saliva will be collected from each subject.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Gingivitis, Plaque
    Keywords
    COMORAL, the oral irrigation unit

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    42 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Control group
    Arm Type
    No Intervention
    Arm Description
    The individuals in the control group will be asked to brush their teeth (2x per day) at home throughout the 4 weeks of study period. They will be asked not to use the supplementary oral hygiene products including mouth rinse, dental floss and chewing gum.
    Arm Title
    Experimental group
    Arm Type
    Experimental
    Arm Description
    The individuals in this group will be asked to brush their teeth (2x per day) at home throughout the 4 weeks of study period. They will be asked not to use the supplementary oral hygiene products including mouth rinse, dental floss and chewing gum. Instead, they will be asked to come to the clinic to use COMORAL® three times a day, every day except Saturday and Sunday.
    Intervention Type
    Device
    Intervention Name(s)
    applying COMORAL®
    Intervention Description
    The individuals in the experimental group will be asked to come to the clinic to use COMORAL® three times a day, every day except Saturday and Sunday.
    Primary Outcome Measure Information:
    Title
    gingival index (GI)
    Description
    the scoring system for mild inflammation(modified gingival index)
    Time Frame
    Baseline, 2 weeks, 4 weeks
    Title
    plaque index (PI)
    Description
    the amount of dental plaque visible on the vestibular and lingual surfaces
    Time Frame
    Baseline, 2 weeks, 4 weeks
    Title
    bleeding on probing (BOP)
    Description
    the scoring system recorded 20 seconds after probing the depth of the pocket
    Time Frame
    Baseline, 2 weeks, 4 weeks
    Title
    pocket depth (PD)
    Description
    the distance from the gingival margin to pocket base
    Time Frame
    Baseline, 2 weeks, 4 weeks
    Title
    gingival recession (GR)
    Description
    the distance of the displacement of marginal gingiva apical to the cemento-enamel junction
    Time Frame
    Baseline, 2 weeks, 4 weeks
    Title
    clinical attachment loss (CAL)
    Description
    the distance between the cementoenamel junction and the base of the probeable pocket
    Time Frame
    Baseline, 2 weeks, 4 weeks
    Secondary Outcome Measure Information:
    Title
    Periopathogens (PP)
    Description
    the amounts of s. mutans, p. gingivalis, and f. nucleatum.
    Time Frame
    Baseline, 2 weeks, 4 weeks

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    25 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: Healthy adult patients (ASA 1-2) aged 18 to 25 with a probing depth of 3mm or less Those with 3 or more natural teeth in each quartile Those who can voluntarily sign the consent form Exclusion Criteria: Existing dental caries Existing periodontitis Other oral diseases
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Reuben Kim, DDS, PhD
    Phone
    (310) 825-7312
    Email
    rkim@dentistry.ucla.edu
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Reuben Kim, DDS, PhD
    Organizational Affiliation
    University of California, Los Angeles
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Learn more about this trial

    COMORAL® the Oral Irrigation Unit Clinical Trial

    We'll reach out to this number within 24 hrs